Cytori Therapeutics (CYTX) Misses Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts CYTX Hot Sheet
Price: $0.21 --0%
Financial Fact:
General and administrative: 1.94M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
General and administrative: 1.94M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Cytori Therapeutics (NASDAQ: CYTX) reported Q4 EPS of ($0.18), $0.01 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $2.38 million versus the consensus estimate of $2.01 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
- McGraw Hill (MH) Tops Q2 EPS by 11c, Beats on Revenue; Offers FY26 Guidance
- Bending Spoons S.p.A. (BSP) Tops Q2 EPS by 19c; offers guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
